Free Trial

agilon health (AGL) Earnings Date, Estimates & Call Transcripts

agilon health logo
$1.68 +0.09 (+5.66%)
(As of 11/20/2024 ET)

agilon health Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 25Estimated
Actual EPS
(Nov. 7)
-$0.29 Missed By -$0.19
Consensus EPS
(Nov. 7)
-$0.10

agilon health released Q3 2024 earnings on November 7, 2024, reporting an EPS of -$0.29, which missed the consensus estimate of -$0.10 by $0.19. Quarterly revenue was reported to be $1.45 billion, below analyst estimates of $1.47 billion. With a trailing EPS of -$0.94, agilon health's earnings are expected to grow next year, from ($0.47) to ($0.32) per share.

AGL Upcoming Earnings

agilon health's next earnings date is estimated for Tuesday, February 25, 2025, based off prior year's reporting schedules.

Get agilon health Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on agilon health and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

AGL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AGL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

agilon health Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243$0.01$0.10$0.04 
Q2 20243-$0.08$0.07-$0.02 
Q3 20243-$0.11$0.04-$0.05 
Q4 20243-$0.27-$0.03-$0.15 
FY 202412-$0.45$0.18-$0.18 
Q1 20252$0.05$0.05$0.05 
Q2 20252-$0.06-$0.02-$0.04 
Q3 20252-$0.19-$0.05-$0.12 
Q4 20252-$0.20-$0.10-$0.15 
FY 20258($0.40)($0.12) ($0.26)

agilon health Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/25/2025
(Estimated)
------- 
11/7/2024Q3 2024-$0.10-$0.29 -$0.19-$0.29$1.47B$1.45B        
8/6/2024Q2 2024-$0.07-$0.07--$0.07$1.56B$1.48B        
5/7/2024Q1 2024-$0.02$0.01+$0.03$0.03$1.62B$1.60B
2/27/2024Q4 2023-$0.28-$0.41 -$0.13-$0.25$1.02B$1.06B    
11/2/2023Q3 2023-$0.05-$0.06 -$0.01-$0.04$1.14B$1.22B
8/3/2023Q2 2023-$0.01-$0.04 -$0.03-$0.04$1.11B$1.15B    
5/9/2023Q1 2023$0.03$0.04+$0.01$0.04$1.08B$1.14B  
3/1/2023Q4 2022-$0.08-$0.14 -$0.06-$0.14$666.32M$689.77M

agilon health Earnings - Frequently Asked Questions

agilon health has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates. Learn more on AGL's earnings history.

agilon health updated its FY 2024 earnings guidance on Thursday, November, 7th. The company issued revenue guidance of $6.1 billion-$6.1 billion, compared to the consensus revenue estimate of $6.0 billion.

In the previous quarter, agilon health (NYSE:AGL) missed the analysts' consensus estimate of ($0.10) by $0.19 with a reported earnings per share (EPS) of ($0.29). Learn more on analysts' earnings estimate vs. AGL's actual earnings.

The conference call for agilon health's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for agilon health's latest earnings report can be read online.
Read Transcript

agilon health (NYSE:AGL) has a recorded annual revenue of $5.59 billion.

agilon health (NYSE:AGL) has a recorded net income of -$262.60 million. AGL has generated -$0.94 earnings per share over the last four quarters.

agilon health's earnings are expected to grow from ($0.47) per share to ($0.32) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NYSE:AGL) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners